Robert Schnepp
- Department of Pediatrics
Adjunct Assistant Professor
-
Aflac Cancer and Blood Disorders Center
Pediatrics
1760 Haygood Drive
Academic Appointment
- Assistant Professor of Pediatrics, Emory University, Atlanta
Education
Degrees
- MD, PhD from University of Pennsylvania
- BS from La Salle University
Research
Publications
-
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study.
J Clin Oncol Volume: 43 Page(s): 2515 - 2526
08/01/2025 Authors: Stein MN; Vinceneux A; Robbrecht D; Doger B; Autio KA; Schweizer MT; Calvo E; Medina L; Van Dongen M; Deville J-L -
Intracranial and systemic progression on amivantamab in platinum-treated epidermal growth factor receptor exon 20 insertion-mutated advanced non-small cell lung cancer.
Lung Cancer Volume: 205 Page(s): 108579
07/01/2025 Authors: Leighl NB; Trigo J; Park K; Lee S-H; Girard N; Viteri S; Garrido P; Krebs MG; Thayu M; Knoblauch RE -
The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.
Mol Oncol Volume: 17 Page(s): 1784 - 1802
09/01/2023 Authors: Shahab SW; Roggeveen CM; Sun J; Kunhiraman H; McSwain LF; Juraschka K; Kumar SA; Saulnier O; Taylor MD; Schniederjan M -
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma.
Cell Rep Med Volume: 4 Page(s): 101091
06/20/2023 Authors: Lee JY; Jonus HC; Sadanand A; Branella GM; Maximov V; Suttapitugsakul S; Schniederjan MJ; Shim J; Ho A; Parwani KK -
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target.
Mol Oncol Volume: 15 Page(s): 2156 - 2171
08/01/2021 Authors: Shields CE; Potlapalli S; Cuya-Smith SM; Chappell SK; Chen D; Martinez D; Pogoriler J; Rathi KS; Patel SA; Oristian KM -
TARGETING THE RNA-BINDING PROTEIN LIN28B IN GROUP 3 MEDULLOBLASTOMA
Volume: 23 Page(s): 8 - 8
06/01/2021 Authors: Shahab S; Schnepp R; MacDonald T; Kenney A -
YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma.
Cancer Res Volume: 80 Page(s): 4741 - 4753
11/01/2020 Authors: Shim J; Lee JY; Jonus HC; Arnold A; Schnepp RW; Janssen KM; Maximov V; Goldsmith KC -
BMI1 constitutes a novel therapeutic vulnerability in fusion-positive rhabdomyosarcoma
Volume: 80 Page(s): 67 - 68
07/01/2020 Authors: Shields CE; Cuya SM; Chappell S; Rathi K; Patel S; Potlapalli S; Schnepp RW -
A LIN28B-PDZ kinase axis promotes neuroblastoma metastasis
Volume: 80 Page(s): 104 - 104
07/01/2020 Authors: Chen D; Cox J; Annam J; Weingart M; Essien G; Rathi K; Khurana P; Cuya S; Harenza JL; Bosse K -
RNA Binding Protein LIN28B: a prime time player shaping neuroblastoma aggression and metastasis.
Oncoscience Volume: 7 Page(s): 52 - 56
07/01/2020 Authors: Chen D; Schnepp RW